Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to conduct a multi-country, multi-site, epidemiologic study designed to assess the proportion of interferon gamma release assay (IGRA) positivity, at site level, and to build capacity to conduct a future TB vaccine efficacy study.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05190146
Study type Observational
Source Bill & Melinda Gates Medical Research Institute
Contact Gates MRI
Phone 18577022108
Email [email protected]
Status Recruiting
Start date December 20, 2021
Completion date June 1, 2024

See also
  Status Clinical Trial Phase
Terminated NCT03028129 - Prevention of Tuberculosis in Prisons Phase 4
Withdrawn NCT03862248 - Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More Phase 3
Completed NCT03271567 - Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients
Completed NCT03199313 - Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid Phase 1
Active, not recruiting NCT03251196 - TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
Recruiting NCT04752592 - Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB N/A
Completed NCT04874948 - Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment Phase 1
Not yet recruiting NCT04995406 - Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary Tuberculosis
Not yet recruiting NCT04919239 - Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB) Phase 2
Not yet recruiting NCT04485156 - Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3) Phase 3
Active, not recruiting NCT02715271 - Study of TB Lesions Obtained in Therapeutical Surgery
Completed NCT01364324 - Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients
Recruiting NCT04179500 - A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant (DR-TB) Pulmonary TB Volunteers (PaSEM) Phase 2
Recruiting NCT05007821 - Linezolid Dosing Strategies in Drug-Resistant TB Phase 2
Recruiting NCT04938596 - Airborne Preventive Measures to Reduce New TB Infections in Household Contacts N/A
Not yet recruiting NCT04734652 - INSTI's For The Management of HIV-associated TB Phase 2
Recruiting NCT03044158 - GeneXpert Performance Evaluation for Linkage to Tuberculosis Care N/A
Completed NCT01130311 - Replacement of Vitamin D in Patients With Active Tuberculosis N/A
Recruiting NCT04122404 - POC Strategies to Improve TB Care in Advanced HIV Disease N/A
Not yet recruiting NCT05047055 - Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients